9850229

2 known cases. View patent page →

Cases
2
Active
0
2 closed
Filed
2022
Top venue
D. Delaware
2 cases

Array BioPharma, Inc. v. Alembic Pharmaceuticals Limited et al.

settled
Docket:
1:22-cv-01277-GBW
Filed:
2022-09-28
Terminated:
2025-06-10
Patents:9314464985022910005761956201695983769980944
π Array BioPharma, Inc.Δ Alembic Pharmaceuticals LimitedΔ Alembic Pharmaceuticals, Inc.

Hatch-Waxman ANDA litigation brought by Array BioPharma against Alembic over generic binimetinib 15 mg tablets (ANDA No. 217678). The case was terminated by stipulated dismissal after a confidential settlement and license agreement, expressly not an adjudication on the merits, with no finding of infringement, invalidity, or unenforceability. A May 28, 2024 stipulated order addressed certain claims but did not become a final, appealable judgment.

Array BioPharma, Inc. v. Sandoz Inc.

settled
Docket:
1:22-cv-01316-GBW
Filed:
2022-10-06
Terminated:
2025-01-09
Patents:9314464985022910005761956201695983769980944
π Array BioPharma, Inc.Δ Sandoz Inc.

Hatch-Waxman ANDA litigation brought by Array BioPharma against Sandoz over generic binimetinib. The case ended in a stipulated dismissal without prejudice under a confidential settlement and license agreement, expressly not an adjudication on the merits; Sandoz could maintain its existing Paragraph IV certifications and FDA was not barred from final ANDA approval. The dismissal order recited '9,850,299'; the narrative states the corresponding family patent is U.S. 9,850,229.